Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-11-01 4:01 pm Purchase |
2022-10-31 | 13G | Zymeworks Inc. ZYME |
EcoR1 Capital, LLC | 7,568,573 12.000% |
1,600,000 (+26.81%) |
Filing History |
| 2022-10-28 5:34 pm Purchase |
2022-10-18 | 13G | NGM Biopharmaceuticals, Inc. NGM |
EcoR1 Capital, LLC | 6,435,518 8.000% |
6,435,518 (New Position) |
Filing History |
| 2022-10-28 5:33 pm Purchase |
2022-10-26 | 13G | Zymeworks Inc. ZYME |
EcoR1 Capital, LLC | 5,968,573 9.900% |
5,968,573 (New Position) |
Filing History |
| 2022-09-26 4:06 pm Purchase |
2022-09-14 | 13G | Edgewise Therapeutics, Inc. EWTX |
EcoR1 Capital, LLC | 3,493,194 5.500% |
3,493,194 (New Position) |
Filing History |
| 2022-09-19 08:27 am Purchase |
2022-09-07 | 13G | SpringWorks Therapeutics, Inc. SWTX |
EcoR1 Capital, LLC | 3,460,208 5.500% |
3,460,208 (New Position) |
Filing History |
| 2022-06-27 4:33 pm Purchase |
2022-06-16 | 13G | Revolution Medicines, Inc. RVMD |
EcoR1 Capital, LLC | 4,278,069 5.800% |
4,278,069 (New Position) |
Filing History |
| 2022-05-16 4:08 pm Purchase |
2022-05-06 | 13G | Arvinas, Inc. ARVN |
EcoR1 Capital, LLC | 3,123,300 5.900% |
3,123,300 (New Position) |
Filing History |
| 2022-04-26 12:58 pm Purchase |
2022-04-21 | 13G | Voyager Therapeutics, Inc. VYGR |
EcoR1 Capital, LLC | 4,276,507 11.100% |
719,000 (+20.21%) |
Filing History |
| 2022-04-11 4:26 pm Purchase |
2022-03-31 | 13G | Reata Pharmaceuticals, Inc. RETA |
EcoR1 Capital, LLC | 1,975,611 6.300% |
1,975,611 (New Position) |
Filing History |
| 2022-04-07 6:23 pm Purchase |
2022-03-02 | 13G | HOOKIPA Pharma Inc. HOOK |
EcoR1 Capital, LLC | 509,086 9.990% |
509,086 (New Position) |
Filing History |
| 2022-03-14 3:55 pm Purchase |
2022-03-11 | 13G | Surface Oncology, Inc. SURF |
EcoR1 Capital, LLC | 4,653,000 9.900% |
4,604,442 (+9482.36%) |
Filing History |
| 2022-02-14 4:55 pm Purchase |
2022-02-04 | 13G | Aligos Therapeutics, Inc. ALGS |
EcoR1 Capital, LLC | 128,532 7.500% |
128,532 (New Position) |
Filing History |
| 2022-02-14 4:02 pm Purchase |
2021-12-31 | 13G | Arcus Biosciences, Inc. RCUS |
EcoR1 Capital, LLC | 5,523,358 7.900% |
951,311 (+20.81%) |
Filing History |
| 2022-02-14 4:01 pm Unchanged |
2021-12-31 | 13G | Voyager Therapeutics, Inc. VYGR |
EcoR1 Capital, LLC | 3,557,507 9.400% |
0 (Unchanged) |
Filing History |
| 2022-02-14 3:58 pm Purchase |
2021-12-31 | 13G | 2seventy bio, Inc. TSVT |
EcoR1 Capital, LLC | 1,917,063 8.200% |
26,400 (+1.40%) |
Filing History |
| 2022-02-14 3:22 pm Sale |
2021-12-31 | 13G | Shattuck Labs, Inc. STTK |
EcoR1 Capital, LLC | 0 0.000% |
-3,295,088 (Position Closed) |
Filing History |
| 2022-02-14 3:21 pm Purchase |
2021-12-31 | 13G | Alector, Inc. ALEC |
EcoR1 Capital, LLC | 4,994,970 6.100% |
252,336 (+5.32%) |
Filing History |
| 2022-02-14 3:21 pm Purchase |
2021-12-31 | 13G | Ovid Therapeutics Inc. OVID |
EcoR1 Capital, LLC | 6,082,200 8.900% |
6,082,200 (New Position) |
Filing History |
| 2022-02-14 3:19 pm Purchase |
2021-12-31 | 13G | Solid Biosciences Inc. SLDB |
EcoR1 Capital, LLC | 613,513 8.300% |
81,667 (+15.36%) |
Filing History |
| 2022-02-14 3:03 pm Purchase |
2021-12-31 | 13G | Avidity Biosciences, Inc. RNA |
EcoR1 Capital, LLC | 2,759,505 5.900% |
655,555 (+31.16%) |
Filing History |